Claims
| Claim | Type | Assessment | Score | Review checks | References |
|---|---|---|---|---|---|
| In the randomized phase 3 LONESTAR trial of 166 immunotherapy-naive patients with metastatic non-small-cell lung cancer, adding local consolidative radiation or surgery after nivolumab plus ipilimumab did not significantly improve overall or progression-free survival. | QUANTITATIVE | Supported | 0.9468 | 0 of 4 | 121 |